@misc{10498/24794,
year = {2021},
month = {1},
url = {http://hdl.handle.net/10498/24794},
abstract = {Adjunctive medical therapy during primary
percutaneous coronary intervention (PPCI) is
based on anticoagulation and antiplatelet drugs. Additionally,
the glycoprotein IIb/IIIa inhibitor (GPI)
abciximab has been shown to reduce infarct size in
some clinical trials [1]. However, the role of intracoronary
fibrinolysis has not been well established
during PPCI. We sought to explore the hypothesis
that a locally administered fibrinolytic could be
more effective in dissolving coronary thrombus
at the macro and microvasculature than adding
a third antiplatelet drug in patients already receiving
double antiplatelet therapy, and therefore improve
myocardial perfusion and left ventricular function.},
publisher = {VIA MEDICA},
title = {Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction},
doi = {10.5603/CJ.a2021.0002},
author = {Morales-Ponce, Francisco J. and González Pérez, Pablo José and Blasco-Turrión, Sara and Sánchez-Brotons, Juan Antonio and Collado-Moreno, Carmen and Martínez-Romero, Pedro and Martínez-Morentín, Eduardo and Caro-Mateo, Pilar},
}